Barely Significant
← all excerpts

Real-World Effectiveness of Tezepelumab in Severe Asthma: A Comparative Analysis of High and Low T2 Phenotypes.

J Pers Med · 2026 · PMC13027941 · PMID 41893035

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

nearly significantp = 0.07so close (0.05 < p ≤ 0.1)
When assessing post-treatment clinical response, there were nearly significant differences between non-T2 and T2 in FEOS (75 [74–81.3] vs. 76 [75–94.5], p = 0.07) ( Table 2 ).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.